RETRACTED: Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Authors:
Preprint
- 19 December 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
The authors have requested that this preprint be removed from Research Square.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Severe asthma gets first biologic in decadesNature Biotechnology, 2016
- Acute and chronic systemic corticosteroid–related complications in patients with severe asthmaJournal of Allergy and Clinical Immunology, 2015
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEuropean Respiratory Journal, 2013
- Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthmaJournal of Allergy and Clinical Immunology, 2012
- Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled StudyAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature ReviewClinical Therapeutics, 2011
- Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patientsCurrent Medical Research and Opinion, 2011
- Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsRheumatology, 2011
- Goodness‐of‐fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity scorePharmacoepidemiology and Drug Safety, 2008